Opportunity timeline
In plain English
DARPA is seeking innovative, awardable solutions for rapidly switchable, non-optogenetic protein domains that enable real-time control inside cells. The tool should support information transfer across cell membranes and supplement existing synthetic biology platforms. Amendment 1 clarifies the notice deadline, but the revised date is not provided.
About this opportunity
UPDATE: The purpose of Amendment 1 to DARPA-SN-26-89, the Non-Optical Methods for High Speed Protein Control Special Notice (SN), is to clarify the notice deadline. DARPA BTO will be actively “shopping” the ERIS Marketplace for innovative, post-competitive, awardable solutions that address the need for a new class of rapidly switchable, non-optogenetic protein domains for real-time cellular control. This effort seeks to develop a robust and versatile molecular tool for massless information transfer across a cell membrane, intended to supplement existing synthetic biology platforms.
Time remaining
Closes Jan 1, 2027
Related Opportunities

DARPA Surgical Competition (DSC) Industry Day

Cryo-Electron Microscopy (Cryo-EM) Services

Human Hindbrain Organoid Functional Assay Services.

Chemical, Biological, Radiological and Nuclear Advance Defense Enabling Network and Clinical Capability (CADENCC)

Study entitled “Malaria and vector borne disease surveillance in the Colombia/Venezuela border”
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-E636F3

